The Alcohol Dehydrogenase Enzymes market is valued at USD 695.8 Million in 2022 and is projected to grow at a CAGR of 6.5% during the forecast period, to reach a value of USD 1,302.0 Million by 2032. Newly released data from Future Market Insights market analysis shows that global Alcohol Dehydrogenase Enzymes demand is projected to grow year-on-year (Y-o-Y) growth of 3.2% in 2022.
| Attributes | Details |
|---|---|
| Market Size Value in 2022 | USD 694.4 Million |
| Market Forecast Value in 2032 | USD 1,302.0 Million |
| Global Growth Rate (2022 to 2032) | 6.5% CAGR |
| Forecast Period | 2022 to 2032 |
| Collective Value Share: Top 3 Countries (2021A) | 39.7% |
Dehydrogenases are used as enzymes to oxidize and degrade carbonyl groups, including those in alcohol. The declination of nicotinamide adenine dinucleotide facilitates the interconversion of aldehydes and alcohols or ketones with the help of a group of dehydrogenase enzymes known as alcohol dehydrogenases.
In addition to helping to break down harmful alcohols in humans and various other species, it also aids in the production of useful aldehyde, ketone, or alcohol groups during the formation of various metabolites. The global market for alcohol dehydrogenase enzymes is now in its infancy, but it is expected to grow rapidly between now and 2020.
The market grew with a CAGR of 6.0% between 2017 and 2021, to create pure stereoisomers of chiral alcohols, alcohol dehydrogenase enzymes are used. It can also be used to research ethanol fuel cells, addiction to drugs and alcohol, and other topics. As a result, there will be a greater global need for alcohol dehydrogenase powder in the future.
Faster economic growth, technological advancements, and the rising prevalence of illnesses brought on by sedentary and overly busy lives will fuel growth in the future. Future market growth may be hampered by factors such as rising interest rates, growing interest in natural and complementary therapies, government-sponsored healthcare programs, and strict government restrictions.
The USA dominates the North American region with a total market share of about 88.7% in 2022 and is expected to continue to experience the same growth throughout the forecast period.
Moreover, the presence of multiple manufacturers such as Sigma-Aldrich and other such companies is quite high in the USA market. This has boosted the availability of alcohol dehydrogenase in the market. As companies are focusing on researching and developing novel innovations that can help explore the world of the enzyme and its wide functionality.
Germany is set to exhibit a CAGR growth rate of nearly 6.3% in the European Alcohol Dehydrogenase Enzymes market during the forecast period. With the immense growth in healthcare in Germany, the Alcohol Dehydrogenase Enzymes market is likely to present lucrative growth.
China is set to exhibit a CAGR growth rate of 8.3% with a market share of over 50% in the East Asian market of Alcohol Dehydrogenase Enzymes during the forecast period. As China is among the most populated country worldwide, making itself a major driver of the Alcohol Dehydrogenase Enzymes market.
Increasing launches and endeavors by market participants to offer quick treatment for resolving patients' problems in the healthcare sector are among the key drivers supporting market growth. Healthcare market tactics based on market trends include expanding the use of bundled payments, utilizing digital tools, developing industry and company collaborations, concentrating on the discovery of new medications, and implementing hybrid imaging technologies. To increase their presence, players in the healthcare sector have chosen strategies like purchasing businesses in related fields and concentrating on providing high-quality goods and services.
In-depth discussions of the company overview, product and service portfolio, corporate expansion strategies, production and manufacturing capacity, financial condition, and worldwide market position are included in the report's section on the competitive landscape. It further illuminates recent business and governmental deals, agreements, partnerships, collaborations, and product debuts.
| Attribute | Details |
|---|---|
| Market Size Value in 2022 | USD 695.8 Million |
| Market Forecast Value in 2032 | USD 1,302.0 Million |
| Global Growth Rate | 6.5% CAGR |
| Forecast Period | 2022 to 2032 |
| Historical Data Available for | 2017 to 2021 |
| Market Analysis | MT for Volume and USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; East Asia; South Asia; Oceania; and Middle East and Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, Chile, Peru, Germany, France, Italy, Spain, United Kingdom, Netherlands, Belgium, Nordic, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Singapore, Australia, New Zealand, GCC Countries, South Africa, Central Africa, North Africa, and others |
| Key Market Segments Covered | Product Type, Application |
| Key Companies Profiled | Sigma-Aldrich; Worthington Biochemical; Alfa Aesar; Roche Diagnostics; MAK Wood; MyBioSource; Calzyme Laboratories Inc; Leebio Solutions; OYC Americas; Others |
| Pricing | Available upon Request |
The Alcohol Dehydrogenase Enzymes market is estimated to reach sales of nearly USD 695.8 Million by 2022.
Alcohol Dehydrogenase Enzymes market revenue is expected to increase at a CAGR of around 6.5% during the period 2022 to 2032.
Alcohol Dehydrogenase Enzymes sales increased a CAGR of around 6.0% over the past half-decade.
The global Alcohol Dehydrogenase Enzymes market value is estimated to be around USD 1,302.0 Million in 2032.
The top countries driving the Alcohol Dehydrogenase Enzymes demand are the USA, Germany, China, and the United Kingdom.
Explore Similar Insights
Alcohol Dehydrogenase Enzymes Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
